Skip to main content
. 2022 Dec 1;482(1):131–145. doi: 10.1007/s00428-022-03460-y

Table 2.

CLL international prognostic index validation dataset. Adapted from [19]

CLL IPI score Patients (%) Median OS (95% CI) 5 year OS (95% CI) 10 year OS (95% CI)
Low 0–1 186 (32%) NR 90.7% (86.4–95.1) 86.5% (80.5–92.4)
Intermediate 2–3 200 (34%) 104 (84–123) 79.8% (83.9–85.8) 40.1% (29.3–50.9)
High 4–6 147 (25%) 63 (51–73) 52.8% (44.5–61.1) 16.1% (6.7–25.4)
Very high 7–10 52 (9%) 31 (20–39) 18.6% (7.5–29.7) 0% (NE)

NR not reached, NE not evaluable